1,3-Bis(5-([2,2'-bipyridin]-6-yl)-1,3,4-oxadiazol-2-yl)benzene

Catalog No. :
ACFGMU410
CAS No. :
866117-19-3
Molecular Formula :
C30H18N8O2
Molecular Weight :
522.53

IUPAC Name:1,3-bis(5-([2,2'-bipyridin]-6-yl)-1,3,4-oxadiazol-2-yl)benzene

1,3-Bis(5-([2,2'-bipyridin]-6-yl)-1,3,4-oxadiazol-2-yl)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Bis(5-([2,2'-bipyridin]-6-yl)-1,3,4-oxadiazol-2-yl)benzene
IUPAC Name1,3-bis(5-([2,2'-bipyridin]-6-yl)-1,3,4-oxadiazol-2-yl)benzene
MDL No.MFCD12022440
Molecular FormulaC30H18N8O2
Molecular Weight522.53
SMILESC1(C2=NN=C(C3=CC=CC(C4=NC=CC=C4)=N3)O2)=CC=CC(C5=NN=C(C6=CC=CC(C7=NC=CC=C7)=N6)O5)=C1
InChI KeyWXDXMXYEAGYOKI-UHFFFAOYSA-N
Synonym866117-19-3 | 1,3-Bis[2-(2,2'-bipyridine-6-yl)-1,3,4-oxadiazo-5-yl]benzene | 2,2'-Bipyridine, 6,6''-[1,3-phenylenebis(1,3,4-oxadiazole-5,2-diyl)]bis- | 1,3-Bis(5-([2,2'-bipyridin]-6-yl)-1,3,4-oxadiazol-2-yl)benzene | 2-(6-pyridin-2-ylpyridin-2-yl)-5-[3-[5-(6-pyri
CAS No.866117-19-3
PubChem CID59336462

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFGMU410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFGMU410 route product structure diagram
    ACFGMU410866117-19-3
Inquiry

2. ACFGMU410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFGMU410 route product structure diagram
    ACFGMU410866117-19-3
Inquiry

Comments (0)